{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:29:27Z","timestamp":1793399367284,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.mayocp.2017.09.015","type":"journal-article","created":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T22:47:35Z","timestamp":1509749255000},"page":"1791-1799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Increased Risk of Multimorbidity in Patients With Sarcoidosis: A Population-Based Cohort Study 1976 to 2013"],"prefix":"10.1016","volume":"92","author":[{"given":"Patompong","family":"Ungprasert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Matteson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia S.","family":"Crowson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mayocp.2017.09.015_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/13814789609162146","article-title":"Comorbidity or multimorbidity: what's in a name? A review of literature","volume":"2","author":"Van den Akker","year":"1996","journal-title":"Eur J Gen Pract"},{"issue":"21-22","key":"10.1016\/j.mayocp.2017.09.015_bib2","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1007\/s00508-016-1090-x","article-title":"Multimorbidity in rheumatic disease","volume":"128","author":"Radner","year":"2016","journal-title":"Wien Klin Wochenschr"},{"issue":"10","key":"10.1016\/j.mayocp.2017.09.015_bib3","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/acr.23171","article-title":"Incidence and prevalence of cardiovascular risk factors among patients with rheumatoid arthritis, psoriasis, or psoriatic arthritis","volume":"69","author":"Radner","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"10.1016\/j.mayocp.2017.09.015_bib4","doi-asserted-by":"crossref","first-page":"e33442","DOI":"10.1371\/journal.pone.0033442","article-title":"Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden","volume":"7","author":"Z\u00f6ller","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.mayocp.2017.09.015_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.semarthrit.2014.03.004","article-title":"Risk of coronary artery disease in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis of observational studies","volume":"44","author":"Ungprasert","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.mayocp.2017.09.015_bib6","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.3899\/jrheum.090011","article-title":"Risk factor for development of coronary artery disease in women with systemic lupus erythematosus","volume":"36","author":"Goldberg","year":"2009","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.mayocp.2017.09.015_bib7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3899\/jrheum.150460","article-title":"Optimal monitoring for coronary heart disease risk in patients with systemic lupus erythematosus: a systematic review","volume":"43","author":"Tselios","year":"2016","journal-title":"J\u00a0Rheumatol"},{"issue":"11","key":"10.1016\/j.mayocp.2017.09.015_bib8","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1001\/jamadermatol.2016.2907","article-title":"Comparison of coronary artery calcium scores between patients with psoriasis and type 2 diabetes","volume":"152","author":"Mansouri","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"11","key":"10.1016\/j.mayocp.2017.09.015_bib9","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1093\/rheumatology\/kev239","article-title":"The impact of multimorbidity status on treatment response in rheumatoid arthritis patients initiating disease-modifying anti-rheumatic drugs","volume":"54","author":"Radner","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.mayocp.2017.09.015_bib10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.mayocp.2015.10.024","article-title":"Epidemiology of sarcoidosis 1946-2013: a population-based study","volume":"91","author":"Ungprasert","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"10.1016\/j.mayocp.2017.09.015_bib11","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.mayocp.2012.08.012","article-title":"History of the Rochester Epidemiology Project: half a century of medical records linkage in a U.S. population","volume":"87","author":"Rocca","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.mayocp.2017.09.015_bib12","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1034\/j.1399-3003.1999.14d02.x","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders","volume":"14","author":"Costabel","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.mayocp.2017.09.015_bib13","doi-asserted-by":"crossref","first-page":"E66","DOI":"10.5888\/pcd10.120239","article-title":"Defining and measuring chronic conditions: imperatives for research, policy, program, and practice","volume":"10","author":"Goodman","year":"2013","journal-title":"Prev Chronic Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2017.09.015_bib14","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01290-2016","article-title":"Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, 1976-2013","volume":"49","author":"Ungprasert","year":"2017","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.mayocp.2017.09.015_bib15","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s00198-017-3962-y","article-title":"Risk of fragility fracture among patients with sarcoidosis: a population-based study 1976-2013","volume":"28","author":"Ungprasert","year":"2017","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.mayocp.2017.09.015_bib16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/acr.22941","article-title":"Risk of malignancy among patients with sarcoidosis: a population-based study","volume":"69","author":"Ungprasert","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"10.1016\/j.mayocp.2017.09.015_bib17","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med"},{"key":"10.1016\/j.mayocp.2017.09.015_bib18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.archger.2016.07.008","article-title":"Multimorbidity and mortality in older adults: a systematic review and meta-analysis","volume":"57","author":"Nunes","year":"2016","journal-title":"Arch Gerontol Geriatr"},{"issue":"20","key":"10.1016\/j.mayocp.2017.09.015_bib19","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1001\/archinte.162.20.2269","article-title":"Prevalence, expenditures, and complications of multiple chronic conditions in the elderly","volume":"162","author":"Wolff","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.mayocp.2017.09.015_bib20","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mayocp.2017.09.015_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/rheumatology\/ken395","article-title":"Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis","volume":"48","author":"Montecucco","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.mayocp.2017.09.015_bib22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4103\/0378-6323.186480","article-title":"Psoriasis and risk of incidental atrial fibrillation: a systematic review and meta-analysis","volume":"82","author":"Ungprasert","year":"2016","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"10","key":"10.1016\/j.mayocp.2017.09.015_bib23","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1172\/JCI11871","article-title":"A\u00a0major role for VCAM-1, but not ICAM-1, in early atherosclerosis","volume":"107","author":"Cybulsky","year":"2001","journal-title":"J\u00a0Clin Invest"},{"issue":"17","key":"10.1016\/j.mayocp.2017.09.015_bib24","doi-asserted-by":"crossref","first-page":"11924","DOI":"10.1074\/jbc.274.17.11924","article-title":"Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase","volume":"274","author":"Rajavashisth","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.mayocp.2017.09.015_bib25","doi-asserted-by":"crossref","unstructured":"Zand H, Morshedzadeh N, Naghashian F. Signaling pathways linking inflammation to insulin resistance [published online ahead of print March 10, 2017]. Diabetes Metab Syndr. https:\/\/doi.org\/10.1016\/j.dsx.2017.03.006.","DOI":"10.1016\/j.dsx.2017.03.006"},{"issue":"4","key":"10.1016\/j.mayocp.2017.09.015_bib26","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1751-7176.2011.00439.x","article-title":"Relationships among insulin resistance, type 2 diabetes, essential hypertension, and cardiovascular disease: similarities and differences","volume":"13","author":"Reaven","year":"2011","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"issue":"3","key":"10.1016\/j.mayocp.2017.09.015_bib27","first-page":"204","article-title":"Two year prognosis of sarcoidosis: the ACCESS experience","volume":"20","author":"Judson","year":"2003","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"3","key":"10.1016\/j.mayocp.2017.09.015_bib28","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ccm.2008.03.006","article-title":"Outcome of sarcoidosis","volume":"29","author":"Nagai","year":"2008","journal-title":"Clin Chest Med"},{"issue":"5","key":"10.1016\/j.mayocp.2017.09.015_bib29","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/MCP.0b013e3283642ad0","article-title":"Nonsteroidal therapy for sarcoidosis","volume":"19","author":"Korsten","year":"2013","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.mayocp.2017.09.015_bib30","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.2147\/TCRM.S74476","article-title":"Management of extrapulmonary sarcoidosis: challenges and solutions","volume":"12","author":"Al-Kofahi","year":"2016","journal-title":"Ther Clin Risk Manag"},{"issue":"4","key":"10.1016\/j.mayocp.2017.09.015_bib31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nri.2017.1","article-title":"Immune regulation by glucocorticoids","volume":"17","author":"Cain","year":"2017","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.mayocp.2017.09.015_bib32","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/hrt.2003.020180","article-title":"Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study","volume":"90","author":"Souverein","year":"2004","journal-title":"Heart"},{"issue":"10","key":"10.1016\/j.mayocp.2017.09.015_bib33","doi-asserted-by":"crossref","first-page":"764","DOI":"10.7326\/0003-4819-141-10-200411160-00007","article-title":"Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease","volume":"141","author":"Wei","year":"2004","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.mayocp.2017.09.015_bib34","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMra1514009","article-title":"Mechanisms, pathophysiology, and management of obesity","volume":"376","author":"Heymsfield","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.mayocp.2017.09.015_bib35","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1378\/chest.14-1099","article-title":"Obesity and weight gain in relation to incidence of sarcoidosis in US black women","volume":"147","author":"Cozier","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.mayocp.2017.09.015_bib36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.rmed.2016.10.003","article-title":"Smoking, obesity and risk of sarcoidosis: a population-based nested case-control study","volume":"120","author":"Ungprasert","year":"2016","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.mayocp.2017.09.015_bib37","first-page":"119","article-title":"The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States","volume":"29","author":"Judson","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2017.09.015_bib38","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1378\/chest.14-1120","article-title":"Racial difference in sarcoidosis mortality in the United States","volume":"147","author":"Mirsaeidi","year":"2015","journal-title":"Chest"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561961730722X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561961730722X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T05:43:03Z","timestamp":1635486183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002561961730722X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S002561961730722X"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2017.09.015","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased Risk of Multimorbidity in Patients With Sarcoidosis: A Population-Based Cohort Study 1976 to 2013","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2017.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}